Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Classement en actions #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Prix de l'action
$2.35
Dernière synchronisation: 2022-09-07
Capitalisation boursière
$162.94K
Changement (1 jour)
2.17%
Changement (1 an)
0.00%
Pays
US
Échange Brickell Biotech, Inc. (BBI)

Catégorie

Historique des divisions d’actions pour Brickell Biotech, Inc. (BBI)
L’action Brickell Biotech, Inc. (symbole : BBI) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 14, 2026.
Une action BBI achetée avant le Aug 14, 2026 équivaudrait aujourd’hui à 0 actions BBI.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE